UVEITIS
Clinical trials for UVEITIS explained in plain language.
Never miss a new study
Get alerted when new UVEITIS trials appear
Sign up with your email to follow new studies for UVEITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with Arthritis-Linked eye disease?
Disease control OngoingThis study tests an oral drug called baricitinib in children aged 2 to 18 with active uveitis linked to juvenile idiopathic arthritis or a related antibody-positive condition. The goal is to see if the drug safely reduces eye inflammation. About 30 participants will receive baric…
Matched conditions: UVEITIS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC
-
Eye fluid clues could revolutionize uveitis treatment
Knowledge-focused OngoingThis study looks at whether proteins in eye fluid can help doctors choose the right immunosuppressive drug for people with non-infectious uveitis, a type of eye inflammation. About 220 participants who haven't responded well to steroids will have their eye fluid tested for 14 dif…
Matched conditions: UVEITIS
Phase: NA • Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC